Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods
Current Microbiology · 2025
DOI: 10.1007/s00284-024-04033-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Jayashri Seetharaman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, 603203, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Molecular Docking Simulation, Microbial Sensitivity Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, 603203, India.
- Department of Microbiology, Intermediate Reference Laboratory, State TB Training and Demonstration Centre, Government Hospital for Chest Diseases, Gorimedu, Puducherry, 605006, India.
- Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, 603203, India. sankarid@srmist.edu.in.
Zitieren
APA
Seetharaman, J., Priya, R. A., Philip, R. R., Muthuraj, M., & Sankari, D. (2025). Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods. Current Microbiology. https://doi.org/10.1007/s00284-024-04033-9
Vancouver
Seetharaman J, Priya RA, Philip RR, Muthuraj M, Sankari D. Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods. Current Microbiology. 2025. doi:10.1007/s00284-024-04033-9
BibTeX
@article{Seetharaman2025,
author = {Seetharaman, Jayashri and Priya, R Akshaya and Philip, Reya Rene and Muthuraj, M and Sankari, D},
title = {Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods},
journal = {Current Microbiology},
year = {2025},
doi = {10.1007/s00284-024-04033-9}
}
EUVIMED